Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

A comparison in an experimental rat model of the effects on adhesion formation of different hemostatic methods used in abdominopelvic surgery.

Mavigök E, Bakacak M, Yazar FM, Bakacak Z, Yaylalı A, Boran ÖF, Bahar AY.

Ginekol Pol. 2019;90(9):507-512. doi: 10.5603/GP.2019.0088.

2.

Pulmonary mucormycosis mimicking an endobronchial mass.

Sayan M, Arpag H, Tokur M, Bahar AY.

Asian Cardiovasc Thorac Ann. 2018 Mar;26(3):242-244. doi: 10.1177/0218492318760711. Epub 2018 Feb 15.

PMID:
29448830
3.

A Case of Pulmonary Alveolar Microlithiasis Diagnosed by Transbronchial Biopsy.

Arpağ H, Sayan M, Atilla N, Bozkuş F, Bahar AY, Kahraman H, Tokur M.

Turk Thorac J. 2017 Oct;18(4):134-136. doi: 10.5152/TurkThoracJ.2017.17015. Epub 2017 Jul 21.

4.

The role of hepcidin and its related genes (BMP6, GDF-15, and HJV) in rats exposed to ischemia and reperfusion.

Dokuyucu R, Demir T, Yumrutaş Onder, Erbağci AB, Orkmez M, Bahar AY, Bayraktar R, Bozgeyik I, Kaplan DS, Cengiz B, Bağci BC.

Turk J Med Sci. 2014;44(4):576-81.

PMID:
25551924
5.

Does imprint cytology improve the accuracy of transrectal prostate needle biopsy?

Sayar H, Bulut BB, Bahar AY, Bahar MR, Seringec N, Resim S, Çıralık H.

Diagn Cytopathol. 2015 Feb;43(2):91-7. doi: 10.1002/dc.23187. Epub 2014 Jun 26.

PMID:
24964902
6.

Improving the identification of high risk precursor B acute lymphoblastic leukemia patients with earlier quantification of minimal residual disease.

Karsa M, Dalla Pozza L, Venn NC, Law T, Shi R, Giles JE, Bahar AY, Cross S, Catchpoole D, Haber M, Marshall GM, Norris MD, Sutton R.

PLoS One. 2013 Oct 11;8(10):e76455. doi: 10.1371/journal.pone.0076455. eCollection 2013.

7.

Comparison of intravitreal vancomycin and daptomycin application in experimental methicillin-resistant Staphylococcus aureus (MRSA) endophthalmitis in rabbits.

Coskun E, Okumus S, Gurler B, Demir T, Bahar AY, Zer Y, Comez A, Tatar MG, Aksoy U, Erbagci I.

Cutan Ocul Toxicol. 2013 Sep;32(3):222-7. doi: 10.3109/15569527.2012.759957. Epub 2013 Feb 1.

PMID:
23368969
8.

Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation.

Weigert O, Kopp N, Lane AA, Yoda A, Dahlberg SE, Neuberg D, Bahar AY, Chapuy B, Kutok JL, Longtine JA, Kuo FC, Haley T, Salois M, Sullivan TJ, Fisher DC, Fox EA, Rodig SJ, Antin JH, Weinstock DM.

Cancer Discov. 2012 Jan;2(1):47-55. doi: 10.1158/2159-8290.CD-11-0208. Epub 2011 Dec 12.

9.

Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia.

Sutton R, Venn NC, Tolisano J, Bahar AY, Giles JE, Ashton LJ, Teague L, Rigutto G, Waters K, Marshall GM, Haber M, Norris MD; Australian and New Zealand Children's Oncology Group.

Br J Haematol. 2009 Aug;146(3):292-9. doi: 10.1111/j.1365-2141.2009.07744.x. Epub 2009 Jun 3.

PMID:
19500099
10.

Determining the repertoire of IGH gene rearrangements to develop molecular markers for minimal residual disease in B-lineage acute lymphoblastic leukemia.

Brisco MJ, Latham S, Sutton R, Hughes E, Wilczek V, van Zanten K, Budgen B, Bahar AY, Malec M, Sykes PJ, Kuss BJ, Waters K, Venn NC, Giles JE, Haber M, Norris MD, Marshall GM, Morley AA.

J Mol Diagn. 2009 May;11(3):194-200. doi: 10.2353/jmoldx.2009.080047. Epub 2009 Mar 26.

11.

Improving minimal residual disease detection in precursor B-ALL based on immunoglobulin-kappa and heavy-chain gene rearrangements.

Sutton R, Bahar AY, Kwan E, Giles JE, Venn NC, Tran S, Hackenberg N, Pozza LD, Marshall GM, Haber M, van der Velden VH, Norris MD.

Leukemia. 2008 Dec;22(12):2265-7. doi: 10.1038/leu.2008.121. Epub 2008 May 22. No abstract available.

PMID:
18496559
12.

Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone.

Choi S, Henderson MJ, Kwan E, Beesley AH, Sutton R, Bahar AY, Giles J, Venn NC, Pozza LD, Baker DL, Marshall GM, Kees UR, Haber M, Norris MD.

Blood. 2007 Jul 15;110(2):632-9. Epub 2007 Mar 19.

PMID:
17371950
13.

The frequency of founder mutations in the BRCA1, BRCA2, and APC genes in Australian Ashkenazi Jews: implications for the generality of U.S. population data.

Bahar AY, Taylor PJ, Andrews L, Proos A, Burnett L, Tucker K, Friedlander M, Buckley MF.

Cancer. 2001 Jul 15;92(2):440-5.

PMID:
11466700

Supplemental Content

Loading ...
Support Center